Vinblastine-induced posterior reversible encephalopathy syndrome. (Record no. 29151068)

MARC details
000 -LEADER
fixed length control field 01583 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518013044.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202001s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1477-092X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/1078155218816776
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ayesh Haj Yousef, Mahmoud H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200120
245 00 - TITLE STATEMENT
Title Vinblastine-induced posterior reversible encephalopathy syndrome.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Date of publication, distribution, etc. Dec 2019
300 ## - PHYSICAL DESCRIPTION
Extent 2019-2022 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bleomycin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dacarbazine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hodgkin Disease
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Posterior Leukoencephalopathy Syndrome
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vinblastine
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eyadeh, Ahmed
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rawashdeh, Rand Al
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Khasawneh, Ruba
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saleh, Judy A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jibreel, Malak J
773 0# - HOST ITEM ENTRY
Title Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Related parts vol. 25
-- no. 8
-- p. 2019-2022
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/1078155218816776">https://doi.org/10.1177/1078155218816776</a>
Public note Available from publisher's website

No items available.